Standard BioTools appoints Fenel Eloi to Board; Bill Colston resigns

STANDARD BIOTOOLS INC.

Bill Colston resigned from Board and Compensation Committee effective March 15, 2023, with no disagreement.
Fenel Eloi appointed to Board as Class I director and to Audit Committee.
Carlos Paya appointed to Compensation Committee.
Eloi is Managing Partner of P&M Capital Partners, former COO/CFO of Cell Signaling Technology.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bill W. Colston

Member of the Board of Directors

LAB · STANDARD BIOTOOLS INC.

Effective: 2023-03-15
Successor: Fenel Eloi
Filed: March 16, 2023, 7:59 PM ET

On March 15, 2023, Bill W. Colston, a member of the board of directors (the “Board”) of Standard BioTools Inc. (the “Company”), notified the Board of his intent to resign from the Board and the compensation committee of the Board, effective March 15, 2023.

Appointed

Fenel Eloi

Class I director

LAB · STANDARD BIOTOOLS INC.

Effective: 2023-03-15
Filed: March 16, 2023, 7:59 PM ET

On March 15, 2023, upon the recommendation of the nominating and corporate governance committee of the Board, the Board appointed Fenel Eloi to fill the Board vacancy created by Mr. Colston’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bill W. Colston resigned as Member of the Board of Directors at STANDARD BIOTOOLS INC..

Action: resigned
Role: Member of the Board of Directors

Exact text from the filing

On March 15, 2023, Bill W. Colston, a member of the board of directors (the “Board”) of Standard BioTools Inc. (the “Company”), notified the Board of his intent to resign from the Board and the compensation committee of the Board, effective March 15, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Fenel Eloi was appointed as Class I director at STANDARD BIOTOOLS INC..

Action: appointed
Role: Class I director

Exact text from the filing

On March 15, 2023, upon the recommendation of the nominating and corporate governance committee of the Board, the Board appointed Fenel Eloi to fill the Board vacancy created by Mr. Colston’s resignation.

View on SEC.gov

STANDARD BIOTOOLS INC. filing history →

Source: SEC EDGAR

accession 0000950142-23-000726

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.